SCHEMBL29000233

SCHEMBL29000233

Cc1ccc(-c2ccc(-c3cc[c]cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 5/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ MCL1 Q07820 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ NISCH Q9Y2I1 2/20 0.37
▸ ENPP3 O14638 1/20 0.37
▸ ENPP1 P22413 1/20 0.37
▸ KIF11 P52732 1/20 0.37
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203945 1.00 ACHE (0.47) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL27872617 0.92 ACHE (0.40) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL27885278 0.90 MCL1 (0.38) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL28070704 0.90 MCL1 (0.38) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL8215851 0.86 MLYCD (0.40) ACHETDP1MCL1CYP2C9HPGD
SCHEMBL28074310 0.86 ALDH1A1 (0.41) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL208526 0.84 ALDH1A1 (0.35) TDP1ALDH1A1
Water SCHEMBL3763584 0.84 ACHE (0.67) ACHETDP1MCL1ALDH1A1CYP2A6
SCHEMBL17200849 0.84 ALDH1A1 (0.35) TDP1ALDH1A1
Water SCHEMBL3680095 0.84 ACHE (0.67) ACHETDP1MCL1ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115894455-A Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2023-04-04 — — CN disclosed
Send feedback